Cardioprotection by systemic dosing of thymosin beta four following ischemic myocardial injury

Thymosin beta 4 (Tβ4) was previously shown to reduce infarct size and improve contractile performance in chronic myocardial ischemic injury via two phases of action: an acute phase, just after injury, when Tβ4 preserves ischemic myocardium via antiapoptotic or anti-inflammatory mechanisms; and a chr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Weike, Ballard, Victoria L., Needle, Saul, Hoang, Bao, Lenhard, Stephen C., Tunstead, James R., Jucker, Beat M., Willette, Robert N., Pipes, G. Teg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843122/
https://www.ncbi.nlm.nih.gov/pubmed/24348421
http://dx.doi.org/10.3389/fphar.2013.00149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843122/
https://www.ncbi.nlm.nih.gov/pubmed/24348421
http://dx.doi.org/10.3389/fphar.2013.00149

Ejemplares similares